Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II TrialFrank A. Giordano, Frederik Wenz, Sven Clausen et al.|Neurosurgery|2018Cited by 55
Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysisVivien N. Sommerlath, Frank A. Giordano, Daniel Buergy et al.|Radiation Oncology|2022Cited by 18
RTHP-05. INTRAOPERATIVE RADIOTHERAPY (IORT) USING LOW-ENERGY X-RAYS IN A COHORT OF PREDOMINANTLY INCOMPLETELY RESECTED NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (INTRAGO TRIAL)Frank A. Giordano, Frederik Wenz, Stefanie Brehmer et al.|Neuro-Oncology|2016Cited by 1
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trialFrank A. Giordano, Piotr Pater, Oliver Ganslandt et al.|The Lancet Oncology|2026Cited by 1